ATLANTA , Feb. 13, 2025 /PRNewswire/ -- Reply, a global systems integrator and technology firm, is proud to announce the launch of Comwrap Reply in North America. This strategic expansion builds on Comwrap Reply's inception in 2004 and established presence in Germany, Italy, and the UK, enhancing its position as a leading provider of AI-powered, end-to-end digital experience solutions.

image for news Reply Announces the Launch of Comwrap Reply to Expand Adobe Expertise in North America

GDEV Inc. announces the appointment of Andrey Fadeev, GDEV's founder and CEO and a member of the Company's Board of Directors, as Chairperson of the Board.

image for news GDEV Aligns Leadership as Founder and CEO Andrey Fadeev Appointed Chairperson of the Board

Quad Announces Increase in Quarterly Dividend — Neutral

QUAD   PRNewsWire — February 13, 2025

SUSSEX, Wis. , Feb. 13, 2025 /PRNewswire/ -- Quad/Graphics, Inc. (NYSE: QUAD) ("Quad" or the "Company"), a global marketing experience company, announced today that its Board of Directors approved an increase in the quarterly dividend on the Company's common stock from $0.05 per share, or $0.20 per share on an annualized basis, to $0.075 per share, or $0.30 per share on an annualized basis.

image for news Quad Announces Increase in Quarterly Dividend

LiveOne (Nasdaq: LVO) Reports Record 9-Month Revenues of $95.1M — Neutral

LVO  PODC   GlobeNewsWire — February 13, 2025

Financial Highlights Audio Division Record Revenue: $90.6M, +13% YoY; Q3 Fiscal 2025 Revenue: $27.1M Audio Division YTD Adjusted EBITDA*: $14.1M; Q3 Fiscal 2025: $3.6M Additional $44M in Contracted Revenue and B2B Deals Closed 5 B2B Deals, Expects to Close 2+ by Year-End, with 70+ in Pipeline 800K Tesla Subscribers, Including 475K+ Ad-Supported, Added 100k+ Following Presentation at Trump's Mar-a-Lago Cash: $10.9M as of Dec. 31, 2024 Cost Savings via Restructurings: $11M $12M Buyback Program Reaffirmed, with $6.2M Remaining PodcastOne (Nasdaq: PODC) LVO Owns ~72% of PodcastOne (Nasdaq: PODC) Acquired 342,000 PODC Shares this Quarter, Totaling 925,000 PODC Shares to Date …

image for news LiveOne (Nasdaq: LVO) Reports Record 9-Month Revenues of $95.1M

Portage, Michigan, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day on Thursday, February 27, 2025 at Citigroup Headquarters, New York, New York.

image for news Stryker to participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day

VANCOUVER, British Columbia, Feb. 13, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions, announces that its subsidiary ZenaDrone has developed and is currently testing a proprietary drone communications management system called “DroneNet” that enables direct and secure drone communications in situations without reliable internet, cellular or satellite communications. The internally developed system is specifically built for use with the Company's ZenaDrone 1000 and IQ series of drone products.

image for news ZenaTech's ZenaDrone Subsidiary Develops and Tests Proprietary Drone Communications System Enabling Secure and Reliable Communications for US Defense Applications

STOUGHTON, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report fourth quarter and full-year 2024 financial results after the market closes on Thursday, February 27, 2025. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET.

image for news Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Kaltura Recognized in the 2025 Gartner® Market Guide for Meeting Solutions — Neutral

KLTR   GlobeNewsWire — February 13, 2025

New York, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Kaltura (Nasdaq: KLTR), the Video Experience Cloud, today announced that it has been recognized as a Representative Vendor in the Gartner Market Guide for Meeting Solutions. Kaltura's AI-infused, real-time-conferencing experience component, Kaltura Room, powers a wide array of synchronous meeting experiences, from marketing, sales, and customer success to teaching, learning, training, certification, corporate communication, collaboration, and more.

image for news Kaltura Recognized in the 2025 Gartner® Market Guide for Meeting Solutions

Bio-Path Holdings Provides Key Clinical Updates — Neutral

BPTH   GlobeNewsWire — February 13, 2025

First Solid Tumor Patient Treated with Second, Higher Dose in Phase 1/1b BP1001-A Clinical Trial Experienced Tumor Reduction and Continued Stable Disease

image for news Bio-Path Holdings Provides Key Clinical Updates

Merus to Present at Citi's 2025 Virtual Oncology Leadership Summit — Neutral

MRUS   GlobeNewsWire — February 13, 2025

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Merus N.V.

image for news Merus to Present at Citi's 2025 Virtual Oncology Leadership Summit

MONTREAL , Feb. 13, 2025 /PRNewswire/ - Lightspeed Commerce Inc. (NYSE: LSPD) (TSX: LSPD) ("Lightspeed" or the "Company"), today released the registration and attendance information for its Capital Markets Day at the New York Stock Exchange on Wednesday, March 26, 2025. Lightspeed is the unified POS and payments platform for ambitious entrepreneurs to accelerate growth, provide the best customer experiences and become a go-to destination in their space.

image for news Lightspeed Announces Registration Information for Capital Markets Day 2025

Dallas Wings Partners with TEGNA's KFAA for Broadcast Rights Agreement — Neutral

TGNA   GlobeNewsWire — February 13, 2025

DALLAS and TYSONS, Va., Feb. 13, 2025 (GLOBE NEWSWIRE) -- The Dallas Wings and TEGNA's (NYSE: TGNA) KFAA in Dallas have announced a landmark broadcast rights agreement, making the station the exclusive local television partner of the Dallas Wings.

image for news Dallas Wings Partners with TEGNA's KFAA for Broadcast Rights Agreement

Clinical trial complexity, logistical challenges associated with treatments, and resource constraints at trial sites cited as top factors that delay enrollment into cell and gene therapy (CGT) clinical trials Despite the increased time required to obtain informed consent, 100% of those surveyed continue to offer patients these innovative investigational treatment options CAMBRIDGE, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today presented novel research evaluating the patient experience and barriers to enrollment and participation in cell and gene therapy (CGT) trials.

image for news Vor Bio Presents Novel Research Highlighting Opportunities and Challenges Facing Institutions Enrolling Patients in Cell and Gene Therapy Trials

Arbe to Participate in February Investor Conferences — Neutral

ARBE   PRNewsWire — February 13, 2025

TEL AVIV, Israel , Feb. 13, 2025 /PRNewswire/ -- Arbe Robotics Ltd. (Nasdaq: ARBE) (TASE: ARBE), a global leader in perception radar solutions, today announced that management will be participating in the following investor conferences in February: Oppenheimer 10th Annual Emerging Growth Conference Format: Virtual meetings When: Tuesday, February 25 Canaccord Sustainability Summit Format: Virtual panel and meetings When: Wednesday, February 26 Investors who wish to schedule one-on-one virtual meeting with Arbe's management during the conferences may refer to their bank contact person or to [email protected].

image for news Arbe to Participate in February Investor Conferences

The results from Phase 1 of the Troculeucel Clinical Trial demonstrated stable/improved outcomes in 90% of subjects, with no drug-related adverse events following troculeucel therapy. Troculeucel therapy was well-tolerated and resulted in beneficial effects on protein aggregate levels and neuroinflammatory biomarkers in the cerebrospinal fluid, with decreases in pTau181 and GFAP appearing to be dose dependent.

image for news NKGen Biotech Announces Publication of Phase 1 Troculeucel Clinical Trial Results for the Treatment of Alzheimer's Disease

LightPath Technologies Announces Strategic Acquisition of G5 Infrared — Neutral

LPTH   PRNewsWire — February 13, 2025

Management to Host Second Quarter Fiscal 2025 Earnings Conference Call to Discuss Transaction at 5:00 p.m. ET Today ORLANDO, Fla.

image for news LightPath Technologies Announces Strategic Acquisition of G5 Infrared

BOSTON, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Wednesday, February 26, 2025 to report its fourth quarter and full year 2024 financial results and provide a corporate update.

image for news Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on Wednesday, February 26, 2025

S&W Announces Second Quarter Fiscal 2025 Financial Results — Neutral

SANW   PRNewsWire — February 13, 2025

LONGMONT, Colo. , Feb. 13, 2025 /PRNewswire/ -- S&W Seed Company (Nasdaq: SANW), or S&W, today announced financial results for the three months ended December 31, 2024.

image for news S&W Announces Second Quarter Fiscal 2025 Financial Results

NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, today announced that members of its executive team will host in-person investor meetings at the Susquehanna Financial Group 14th Annual Technology Conference in New York City on Thursday, February 27, 2025. About Magnite We're Magnite (NASDAQ: MGNI), the world's largest independent sell-side advertising company.

image for news Magnite to Participate in the Susquehanna Financial Group 14th Annual Technology Conference

Based on FAA Part 107 commercial drone registration data from 2021 to the present day marks a significant accomplishment for AgEagle in the commercial UAS industry WICHITA, Kan., Feb. 13, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS) a leading provider of best-in-class unmanned aerial systems (UAS), sensors and software solutions for customers worldwide in the commercial and government verticals, announces that based on its internal review of FAA Part 107 commercial drone registration data from 2021 to present day indicates the Company's eBee UAS was the most used conventional fixed wing drone for U.S. commercial operators.

image for news AgEagle Aerial Systems Announces eBee is the Most Used Conventional Fixed Wing Drone for U.S. Commercial Operators Based on Federal Aviation Administration (FAA) Registration Data